Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Cancer Therapy: Preclinical

Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity

Robin J. Prestwich, Fiona Errington, Elizabeth J. Ilett, Ruth S.M. Morgan, Karen J. Scott, Timothy Kottke, Jill Thompson, Ewan E. Morrison, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile and Alan A. Melcher
Robin J. Prestwich
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fiona Errington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth J. Ilett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ruth S.M. Morgan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen J. Scott
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy Kottke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jill Thompson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ewan E. Morrison
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin J. Harrington
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hardev S. Pandha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Selby
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard G. Vile
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan A. Melcher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-08-0831 Published November 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: November 2008 to January 2021

AbstractFull-text HTMLPDF
Total237921681586

Cited By

Article Information

Volume 14, Issue 22, pp. 7358-7366

DOI 
https://doi.org/10.1158/1078-0432.CCR-08-0831
PubMed 
19010851

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted May 23, 2008
  • Received April 1, 2008
  • Revision received May 23, 2008
  • Published first November 14, 2008.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Robin J. Prestwich1,
  2. Fiona Errington1,
  3. Elizabeth J. Ilett1,
  4. Ruth S.M. Morgan1,
  5. Karen J. Scott1,
  6. Timothy Kottke2,
  7. Jill Thompson2,
  8. Ewan E. Morrison1,
  9. Kevin J. Harrington4,
  10. Hardev S. Pandha5,
  11. Peter J. Selby1,
  12. Richard G. Vile1,2,3 and
  13. Alan A. Melcher1
  1. Authors' Affiliations:1Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom; 2Molecular Medicine Program and 3Department of Immunology, Mayo Clinic, Rochester, Minnesota; 4Targeted Therapy Laboratory, Institute of Cancer Research, Cancer Research UK, Centre for Cell and Molecular Biology, Chester Beatty Laboratories, London, United Kingdom; and 5Oncology, Postgraduate Medical School, University of Surrey, Guildford, United Kingdom
  1. Requests for reprints:
    Alan A. Melcher, St. James's University Hospital, Level 5, Welcome Trust Brenner Building, Beckett Street, Leeds LS9 7TF, United Kingdom. Phone: 44-113-3438436; Fax: 44-113-2429886; E-mail: A.A.Melcher{at}leeds.ac.uk.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 14 (22)
November 2008
Volume 14, Issue 22
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Robin J. Prestwich, Fiona Errington, Elizabeth J. Ilett, Ruth S.M. Morgan, Karen J. Scott, Timothy Kottke, Jill Thompson, Ewan E. Morrison, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile and Alan A. Melcher
Clin Cancer Res November 15 2008 (14) (22) 7358-7366; DOI: 10.1158/1078-0432.CCR-08-0831

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity
Robin J. Prestwich, Fiona Errington, Elizabeth J. Ilett, Ruth S.M. Morgan, Karen J. Scott, Timothy Kottke, Jill Thompson, Ewan E. Morrison, Kevin J. Harrington, Hardev S. Pandha, Peter J. Selby, Richard G. Vile and Alan A. Melcher
Clin Cancer Res November 15 2008 (14) (22) 7358-7366; DOI: 10.1158/1078-0432.CCR-08-0831
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Combined VEGF/EGFR Inhibition
  • Radiotherapy with IDO1/PD-1 Blockade Treats Advanced GBM
  • Enhanced Delivery of SN38-TOA NPs in NBs
Show more Cancer Therapy: Preclinical
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement